144 related articles for article (PubMed ID: 35853280)
1. PLGA microspheres carrying miR-20a-5p improved intestinal epithelial barrier function in patients with Crohn's disease through STAT3-mediated inhibition of Th17 differentiation.
Wang H; Xing H; Xia Y; Zhou Y; Zhou J; Li L; Tao W; Liu Q; Wang Y; Zhao J; Yuan Y; Zhang C; Zhu W
Int Immunopharmacol; 2022 Sep; 110():109025. PubMed ID: 35853280
[TBL] [Abstract][Full Text] [Related]
2. PLGA-microspheres-carried circGMCL1 protects against Crohn's colitis through alleviating NLRP3 inflammasome-induced pyroptosis by promoting autophagy.
Zhao J; Sun Y; Yang H; Qian J; Zhou Y; Gong Y; Dai Y; Jiao Y; Zhu W; Wang H; Lin Z; Tang L
Cell Death Dis; 2022 Sep; 13(9):782. PubMed ID: 36088391
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-590-5p Inhibits Intestinal Inflammation by Targeting YAP.
Yu M; Luo Y; Cong Z; Mu Y; Qiu Y; Zhong M
J Crohns Colitis; 2018 Jul; 12(8):993-1004. PubMed ID: 29912317
[TBL] [Abstract][Full Text] [Related]
4. MALAT1 Maintains the Intestinal Mucosal Homeostasis in Crohn's Disease via the miR-146b-5p-CLDN11/NUMB Pathway.
Li Y; Zhu L; Chen P; Wang Y; Yang G; Zhou G; Li L; Feng R; Qiu Y; Han J; Chen B; He Y; Zeng Z; Chen M; Zhang S
J Crohns Colitis; 2021 Sep; 15(9):1542-1557. PubMed ID: 33677577
[TBL] [Abstract][Full Text] [Related]
5. circSMAD4 Promotes Experimental Colitis and Impairs Intestinal Barrier Functions by Targeting Janus Kinase 2 Through Sponging miR-135a-5p.
Zhao J; Lin Z; Ying P; Zhao Z; Yang H; Qian J; Gong Y; Zhou Y; Dai Y; Jiao Y; Zhu W; Wang H; Tang L
J Crohns Colitis; 2023 Apr; 17(4):593-613. PubMed ID: 36239525
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease.
Zhuang X; Chen B; Huang S; Han J; Zhou G; Xu S; Chen M; Zeng Z; Zhang S
EBioMedicine; 2022 Feb; 76():103846. PubMed ID: 35124427
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-124 Promotes Intestinal Inflammation by Targeting Aryl Hydrocarbon Receptor in Crohn's Disease.
Zhao Y; Ma T; Chen W; Chen Y; Li M; Ren L; Chen J; Cao R; Feng Y; Zhang H; Shi R
J Crohns Colitis; 2016 Jun; 10(6):703-12. PubMed ID: 26802080
[TBL] [Abstract][Full Text] [Related]
8. miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease.
Huang Z; Shi T; Zhou Q; Shi S; Zhao R; Shi H; Dong L; Zhang C; Zeng K; Chen J; Zhang J
Gut; 2014 Aug; 63(8):1247-57. PubMed ID: 24000293
[TBL] [Abstract][Full Text] [Related]
9. An altered expression of miR-376a-3p and miR-20a-5p in peripheral blood exosomes regulates the autophagy and inflammatory systemic substrates, and relates to the smoking habit and age in Crohn's disease.
Caparrós E; García-Martinez I; Pedro Zapater ; Lucía Madero ; Valverde ÁM; Ana Gutiérrez ; Francés R
FASEB J; 2024 Jan; 38(2):e23418. PubMed ID: 38226870
[TBL] [Abstract][Full Text] [Related]
10. miR-130a-3p, a Preclinical Therapeutic Target for Crohn's Disease.
Zhao J; Wang H; Zhou J; Qian J; Yang H; Zhou Y; Ding H; Gong Y; Qi X; Jiao Y; Ying P; Tang L; Sun Y; Zhu W
J Crohns Colitis; 2021 Apr; 15(4):647-664. PubMed ID: 33022049
[TBL] [Abstract][Full Text] [Related]
11. MiR-20a-5p suppressed TGF-β1-triggered apoptosis of human bronchial epithelial BEAS-2B cells by targeting STAT3.
Lv X; Wang L; Zhu T
Mol Cell Probes; 2020 Apr; 50():101499. PubMed ID: 31883454
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
13. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.
Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH
World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139
[TBL] [Abstract][Full Text] [Related]
14. The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling.
Mahurkar-Joshi S; Rankin CR; Videlock EJ; Soroosh A; Verma A; Khandadash A; Iliopoulos D; Pothoulakis C; Mayer EA; Chang L
Gastroenterology; 2021 Jun; 160(7):2409-2422.e19. PubMed ID: 33617890
[TBL] [Abstract][Full Text] [Related]
15. Mucosal MicroRNAs Expression Profiles before and after Exclusive Enteral Nutrition Therapy in Adult Patients with Crohn's Disease.
Guo Z; Gong J; Li Y; Gu L; Cao L; Wang Z; Zhu W; Li J
Nutrients; 2016 Aug; 8(8):. PubMed ID: 27556489
[TBL] [Abstract][Full Text] [Related]
16. Decreased Colonic Activin Receptor-Like Kinase 1 Disrupts Epithelial Barrier Integrity in Patients With Crohn's Disease.
Toyonaga T; Steinbach EC; Keith BP; Barrow JB; Schaner MR; Wolber EA; Beasley C; Huling J; Wang Y; Allbritton NL; Chaumont N; Sadiq TS; Koruda MJ; Jain A; Long MD; Barnes EL; Herfarth HH; Isaacs KL; Hansen JJ; Shanahan MT; Rahbar R; Furey TS; Sethupathy P; Sheikh SZ
Cell Mol Gastroenterol Hepatol; 2020; 10(4):779-796. PubMed ID: 32561494
[TBL] [Abstract][Full Text] [Related]
17. MiR-124a Mediates the Impairment of Intestinal Epithelial Integrity by Targeting Aryl Hydrocarbon Receptor in Crohn's Disease.
Zhao X; Li J; Ma J; Jiao C; Qiu X; Cui X; Wang D; Zhang H
Inflammation; 2020 Oct; 43(5):1862-1875. PubMed ID: 32607693
[TBL] [Abstract][Full Text] [Related]
18. Fecal MicroRNAs Show Promise as Noninvasive Crohn's Disease Biomarkers.
Wohnhaas CT; Schmid R; Rolser M; Kaaru E; Langgartner D; Rieber K; Strobel B; Eisele C; Wiech F; Jakob I; Gantner F; Herichova I; Vinisko R; Böcher WO; Visvanathan S; Shen F; Panzenbeck M; Raymond E; Reber SO; Delić D; Baum P
Crohns Colitis 360; 2020 Jan; 2(1):otaa003. PubMed ID: 32551441
[TBL] [Abstract][Full Text] [Related]
19. miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation.
Wang M; Gu H; Qian H; Zhu W; Zhao C; Zhang X; Tao Y; Zhang L; Xu W
Eur J Cancer; 2013 May; 49(8):2010-21. PubMed ID: 23333058
[TBL] [Abstract][Full Text] [Related]
20. Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn's disease.
Zhou L; Zhu L; Wu X; Hu S; Zhang S; Ning M; Yu J; Chen M
BMC Med; 2023 Aug; 21(1):287. PubMed ID: 37542259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
